z-logo
open-access-imgOpen Access
Avapritinib: preclinical studies of a promising novel therapeutic option for gastrointestinal stromal tumors
Author(s) -
Milena Urbini
Publication year - 2019
Publication title -
gastrointestinal stromal tumor
Language(s) - English
Resource type - Journals
ISSN - 2663-1911
DOI - 10.21037/gist.2019.01.03
Subject(s) - pdgfra , gastrointestinal tract , gist , malignancy , tyrosine kinase inhibitor , stromal cell , mesenchymal stem cell , tyrosine kinase , receptor tyrosine kinase , cancer research , medicine , targeted therapy , proto oncogene proteins c kit , sunitinib , stromal tumor , imatinib , oncology , bioinformatics , pathology , biology , receptor , cancer , stem cell , myeloid leukemia , haematopoiesis , stem cell factor , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here